+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Ursolic Acid Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Ursolic Acid Market - Forecasts from 2022 to 2027

  • Report
  • July 2022
  • 145 Pages
  • Global
From
From
From
Melanoma Treatment Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Melanoma Treatment Market - Forecasts from 2022 to 2027

  • Report
  • May 2022
  • 120 Pages
  • Global
From
USA Antibody Drug Conjugates Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

USA Antibody Drug Conjugates Market - Forecasts from 2022 to 2027

  • Report
  • April 2022
  • 80 Pages
  • United States
From
From
Human Papilloma Virus (HPV) Market - Forecasts from 2019 to 2024 - Product Thumbnail Image

Human Papilloma Virus (HPV) Market - Forecasts from 2019 to 2024

  • Report
  • November 2019
  • 115 Pages
  • Global
From
From
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more